Comparison Of iNfliximab and ciclosporin in STeroid Resistant Ulcerative Colitis: pragmatic randomised Trial and economic evaluation (CONSTRUCT) | Zendy

John G Williams | Zendy; M Fasihul Alam | Zendy; Laith Alrubaiy | Zendy; Clare Clement | Zendy; David Cohen | Zendy; Michelle Grey | Zendy; Mike Hilton | Zendy; Hayley Hutchings | Zendy; Mirella Longo | Zendy; Jayne M Morgan | Zendy; Frances Rapport | Zendy; Anne C Seagrove | Zendy; Alan Watkins | Zendy

Open Access

Comparison Of iNfliximab and ciclosporin in STeroid Resistant Ulcerative Colitis: pragmatic randomised Trial and economic evaluation (CONSTRUCT)

Author(s) -

John G Williams,

M Fasihul Alam,

Laith Alrubaiy,

Clare Clement,

David Cohen,

Michelle Grey,

Mike Hilton,

Hayley Hutchings,

Mirella Longo,

Jayne M Morgan,

Frances Rapport,

Anne C Seagrove,

Alan Watkins

Publication year - 2016

Publication title -

health technology assessment

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.426

H-Index - 126

eISSN - 2046-4924

pISSN - 1366-5278

DOI - 10.3310/hta20440

Subject(s) - medicine , infliximab , ciclosporin , ulcerative colitis , randomized controlled trial , quality of life (healthcare) , surgery , transplantation , nursing , disease

The efficacy of infliximab and ciclosporin in treating severe ulcerative colitis (UC) is proven, but there has been no comparative evaluation of effectiveness.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research